President Donald Trump has found himself in an odd juxtaposition as traditional allies are pushing back on his Most Favored Nation (MFN) plan to reduce the price of prescription drugs. < | As ...
First patient successfully enrolled in global registrational study in Australia - Operational presence in Australia positions Serina to advance ...
MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST) ...
First patient successfully enrolled in global registrational study in Australia - Operational presence in Australia positions Serina to advance enrollment in Cohort 1- Company remains on track for ...
MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST)Meg Flippin, Benzinga Staff Writer CARDIFF, UK / ACCESS Newswire / February 19, 202 ...
The TV doctor announced he was leaving his former roles back in October, facing the brunt of the broadcaster's cuts announced last May.
This new filing is not an isolated event but represents another front in a protracted legal war between the two biotech firms. The conflict has a precedent: Moderna originally sued both BioNTech and ...
22hon MSN
US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost
By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it ...
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...
Some residents in the Philadelphia suburb of Quakertown are calling for the police chief to resign after a scuffle between police and students protesting ICE policies left several juveniles in ...
Explore FDA's QMSR and cybersecurity mandates for medical devices, including SPDF, SBOMs, and legacy medical device ...
At an event on Monday, the agency officially unveiled long-awaited draft guidance meant to help speed the development of bespoke treatments for extremely rare diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results